EP0682714A4 - Novel neutrophil inhibitors. - Google Patents

Novel neutrophil inhibitors.

Info

Publication number
EP0682714A4
EP0682714A4 EP94907114A EP94907114A EP0682714A4 EP 0682714 A4 EP0682714 A4 EP 0682714A4 EP 94907114 A EP94907114 A EP 94907114A EP 94907114 A EP94907114 A EP 94907114A EP 0682714 A4 EP0682714 A4 EP 0682714A4
Authority
EP
European Patent Office
Prior art keywords
neutrophil inhibitors
novel neutrophil
novel
inhibitors
neutrophil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP94907114A
Other languages
German (de)
French (fr)
Other versions
EP0682714A1 (en
Inventor
Matthew Moyle
David Lee Foster
George Phillip Vlasuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dendreon Pharmaceuticals LLC
Original Assignee
Corvas International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/060,433 external-priority patent/US6756211B1/en
Priority claimed from US08/151,064 external-priority patent/US6962795B1/en
Application filed by Corvas International Inc filed Critical Corvas International Inc
Publication of EP0682714A1 publication Critical patent/EP0682714A1/en
Publication of EP0682714A4 publication Critical patent/EP0682714A4/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02BINTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00Other engines
    • F02B75/02Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP94907114A 1992-12-24 1993-12-23 Novel neutrophil inhibitors. Ceased EP0682714A4 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US99697292A 1992-12-24 1992-12-24
US996972 1992-12-24
US60433 1993-05-11
US08/060,433 US6756211B1 (en) 1992-05-11 1993-05-11 Neutropohil inhibitors
US08/151,064 US6962795B1 (en) 1992-05-11 1993-11-10 Neutrophil inhibitors
US151064 1993-11-10
PCT/US1993/012626 WO1994014973A1 (en) 1992-12-24 1993-12-23 Novel neutrophil inhibitors

Publications (2)

Publication Number Publication Date
EP0682714A1 EP0682714A1 (en) 1995-11-22
EP0682714A4 true EP0682714A4 (en) 1997-06-11

Family

ID=27369840

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94907114A Ceased EP0682714A4 (en) 1992-12-24 1993-12-23 Novel neutrophil inhibitors.

Country Status (6)

Country Link
EP (1) EP0682714A4 (en)
JP (1) JPH08505055A (en)
AU (1) AU694103B2 (en)
CA (1) CA2152599A1 (en)
NZ (2) NZ261662A (en)
WO (1) WO1994014973A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4524816B2 (en) * 1998-07-06 2010-08-18 東ソー株式会社 IL-6 receptor / IL-6 direct fusion protein
CN101245110B (en) * 2007-02-16 2010-09-15 鲁南制药集团股份有限公司 Recombined leukocyte inhibition factor and hirudo nipponica former peg-and-socket joint protein and pharmaceutical composition
CN115057915B (en) * 2021-12-28 2024-04-26 四川农业大学 Application of escherichia coli expression protein Cry5B in preparation of active medicines for resisting panda roundworm adults and L4 stage larvae

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338305A (en) * 1975-03-24 1982-07-06 American Home Products Corporation Use of LRH and LRH agonists
US4591552A (en) * 1982-09-29 1986-05-27 New York Blood Center, Inc. Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide
CA1339101C (en) * 1986-06-03 1997-07-29 Nicolaas Overbeeke Production of guar alpha-galactosidase and immunologically related alpha-galactosidases by host organisms transformed with recombinant dna methods

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
F.BRUSCHI ET AL.: "Inhibition of Leukocyte Function by Serum from Patients with Trichinellosis", JOURNAL OF PARASITOLOGY, vol. 76, no. 4, August 1991 (1991-08-01), pages 577 - 579, XP000647991 *
O. DUVAUX-MIRET ET AL.: "Immunosuppression in the definitive and intermediate hosts of the human parasite Schistosoma mansoni by release of immunoactive neuropeptides", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 89, no. 2, 15 January 1992 (1992-01-15), WASHINGTON US, pages 778 - 781, XP002029196 *
R.M. MAIZELS ET AL.: "Immunological modulation and evasion by helminth parasites in human populations", NATURE, vol. 365, no. 6449, 28 October 1993 (1993-10-28), LONDON GB, pages 797 - 805, XP002029167 *
R.W. LEID ET AL.: "Inhibition of Neutrophil Aggregation by Taeniaestatin, a Cestode Proteinase Inhibitor", INTERNATIONAL JOURNAL OF PARASITOLOGY, vol. 17, no. 7, 1987, pages 1349 - 1353, XP000647910 *
See also references of WO9414973A1 *

Also Published As

Publication number Publication date
JPH08505055A (en) 1996-06-04
AU6080594A (en) 1994-07-19
AU694103B2 (en) 1998-07-16
NZ261662A (en) 1997-03-24
CA2152599A1 (en) 1994-07-07
WO1994014973A1 (en) 1994-07-07
EP0682714A1 (en) 1995-11-22
NZ314241A (en) 1999-01-28

Similar Documents

Publication Publication Date Title
EP0601322A3 (en) Adenosindeaminase inhibitor.
EP0597463A3 (en) Thermotherapiesonde.
EP0580285A3 (en) Auto-reclosers.
ZA939656B (en) Microvicidal compositions.
EP0598412A3 (en) Skinprotection composition.
EP0655440A3 (en) 1-Aminoethylindoles.
EP0641704A3 (en) Monowheel travois.
GR1002074B (en) Rotomett granulation.
EP0578228A3 (en) Microactuator.
EP0671929A4 (en) Compositions.
EP0630245A4 (en) Protein kinase c inhibitor.
EP0633771A4 (en) Compounds.
ZA946728B (en) Tocopherois.
EP0620223A3 (en) Tetrahydro-pyrido-indole.
EP0602808A3 (en) Cache systems.
EP0572808A3 (en) Antiblocage-system.
EP0586828A3 (en) Hydrophone.
EP0620043A3 (en) Desintegrator for solid objects.
EP0668864A4 (en) Substituted biphenylmethylimidazopyridines.
ZA93782B (en) Determination method.
CA72592S (en) Block
EP0578138A3 (en) Gene-detecting method.
EP0599191A3 (en) Speed-governor-circuit.
EP0609763A3 (en) Ph-glasselectrode.
EP0592354A3 (en) Vacuum-centrifuge.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950712

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RHK1 Main classification (correction)

Ipc: C12N 15/00

A4 Supplementary search report drawn up and despatched

Effective date: 19970425

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20001211

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20071223